Pulmonx Chartis Tablet Console— 510(k) K180011
Substantially EquivalentPulmonx Corporation
FDA 510(k) clearance K180011 for Pulmonx Chartis Tablet Console, Substantially Equivalent on 2018-07-13. Applicant: Pulmonx Corporation. Device class: 2.
Clearance details
- Applicant
- Pulmonx Corporation
- Product code
- Code BZG
- Device class
- Class 2
- Regulation
- 21 CFR 868.1840
- Advisory panel
- Anesthesiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Redwood City, CA, US
Recent devices under product code BZG
view allMore clearances from Pulmonx Corporation
view allData sourced from openFDA. This site is unofficial and independent of the FDA.